Q4 2022 Theriva Biologics Inc Earnings Call Transcript

Mar 30, 2023 / 12:30PM GMT
Operator

Greetings. Welcome to Theriva Biologics 2022 full year operational highlights and financial results conference call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to Chris Calabrese with LifeSci Advisors. Thank you. You may begin.

Chris Calabrese -

Thank you, operator, and good morning, everyone. Welcome to the Theriva Biologics Full Year 2022 Investor Conference Call. Leading the call today will be Steven Shallcross, Chief Executive and Chief Financial Officer of Theriva Biologics. Dr. Manel Cascalló, General Director of Theriva Biologics, European subsidiary; Dr. Frank Tufaro, Chief Operating Officer; and Dr. Vince Wacher, Head of Corporate and Product Development of Theriva Biologics are also on the call and will be available to answer questions during the Q&A session.

Theriva Biologics issued a press release this morning, which provided operational highlights and included the financial results for the full year ending December 31, 2022. The press release can be found in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot